Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PG324 vs Components in Glaucoma/OHT
NCT02057575Phase 2Completed
- Sponsor
- Aerie Pharmaceuticals
- Start
- Jan 2014
- Primary completion
- Jun 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of netarsudil + latanoprost in open-angle glaucoma (OAG), ocular hypertension, sponsored by Aerie Pharmaceuticals. Started Jan 2014; status: completed.
02
Drugs
netarsudil + latanoprost
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT02057575.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02057575.